 degree in bacteriology from UCLA, and a Ph.D in medical microbiology and immunology from UCLA School of Medicine.He was known for his commitment to improving blood safety, his work in transgenic proteins to treat hemophilia and other blood-related disorders, as well contributions in investigating mad cow disease in the blood supply.His career included positions with the National Cancer Institute, the American Red Cross, and private companies that treated blood-borne disorders, most recently as Chief Scientific Officer at Inspiration Biopharmaceuticals, and previously President and subsequently Chief Scientific Officer of Clearant.